ZA923711B - Use of nizatidine to treat reflux esophagitis - Google Patents
Use of nizatidine to treat reflux esophagitisInfo
- Publication number
- ZA923711B ZA923711B ZA923711A ZA923711A ZA923711B ZA 923711 B ZA923711 B ZA 923711B ZA 923711 A ZA923711 A ZA 923711A ZA 923711 A ZA923711 A ZA 923711A ZA 923711 B ZA923711 B ZA 923711B
- Authority
- ZA
- South Africa
- Prior art keywords
- nizatidine
- reflux esophagitis
- treat reflux
- treat
- esophagitis
- Prior art date
Links
- 208000021302 gastroesophageal reflux disease Diseases 0.000 title 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 title 1
- 229960004872 nizatidine Drugs 0.000 title 1
- 208000000689 peptic esophagitis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70614591A | 1991-05-28 | 1991-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA923711B true ZA923711B (en) | 1993-11-22 |
Family
ID=24836392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA923711A ZA923711B (en) | 1991-05-28 | 1992-05-22 | Use of nizatidine to treat reflux esophagitis |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0516345A1 (enExample) |
| JP (1) | JPH05148142A (enExample) |
| KR (1) | KR920021144A (enExample) |
| AU (1) | AU1721892A (enExample) |
| CA (1) | CA2069162A1 (enExample) |
| HU (1) | HU9201751D0 (enExample) |
| MX (1) | MX9202507A (enExample) |
| NO (1) | NO922019L (enExample) |
| TW (1) | TW202387B (enExample) |
| ZA (1) | ZA923711B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| WO2006047493A2 (en) | 2004-10-21 | 2006-05-04 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| DK3354276T3 (da) * | 2007-11-13 | 2020-03-30 | Meritage Pharma Inc | Sammensætninger til behandlingen af gastrointestinal inflammation |
| SG10201407965XA (en) | 2009-12-02 | 2015-02-27 | Aptalis Pharma Ltd | Fexofenadine microcapsules and compositions containing them |
-
1992
- 1992-05-21 TW TW081103962A patent/TW202387B/zh active
- 1992-05-21 EP EP92304634A patent/EP0516345A1/en not_active Withdrawn
- 1992-05-21 CA CA002069162A patent/CA2069162A1/en not_active Abandoned
- 1992-05-22 ZA ZA923711A patent/ZA923711B/xx unknown
- 1992-05-22 NO NO92922019A patent/NO922019L/no unknown
- 1992-05-26 HU HU9201751A patent/HU9201751D0/hu unknown
- 1992-05-26 KR KR1019920008916A patent/KR920021144A/ko not_active Withdrawn
- 1992-05-27 JP JP4134856A patent/JPH05148142A/ja not_active Withdrawn
- 1992-05-27 MX MX9202507A patent/MX9202507A/es unknown
- 1992-05-27 AU AU17218/92A patent/AU1721892A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO922019L (no) | 1992-11-30 |
| CA2069162A1 (en) | 1992-11-29 |
| JPH05148142A (ja) | 1993-06-15 |
| NO922019D0 (no) | 1992-05-22 |
| AU1721892A (en) | 1992-12-03 |
| TW202387B (enExample) | 1993-03-21 |
| EP0516345A1 (en) | 1992-12-02 |
| MX9202507A (es) | 1992-11-01 |
| KR920021144A (ko) | 1992-12-18 |
| HU9201751D0 (en) | 1992-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI951413A7 (fi) | Pintakäsittelykoostumus | |
| AU1532492A (en) | Use of heterocyclic compounds for the treatment of inflammatory pain | |
| GB2213919B (en) | Surface treatment of refractories | |
| AP9200459A0 (en) | Treatment of wastewater | |
| ZA931489B (en) | Use of interleuken-10 to suppress graft-vs-host disease | |
| ZA924611B (en) | Treatment of water | |
| HU9301209D0 (en) | Preparative for treatment of surface | |
| AU1721892A (en) | Use of nizatidine to treat reflux esophagitis | |
| AR243138A1 (es) | Procedimiento para el tratamiento de un efluente acuoso. | |
| ZA937832B (en) | Treatment of wood | |
| GB2269223B (en) | Surface treatment of refractories | |
| DK159088A (da) | Overfladebehandlingskompostition | |
| EP0467369A3 (en) | Use of furosemide to treat allergic conjunctivitis | |
| GB9117258D0 (en) | Use of radicals | |
| NZ250159A (en) | Use of furan-3-carboxamides as microbicides | |
| IL101655A0 (en) | Use of r(+)-3-amino-1-hydroxy-pyrrolidin-2-one for treating anxiety | |
| GB9125670D0 (en) | Treatment of neurogical conditions | |
| GB9101958D0 (en) | Treatment of oil | |
| GB9112307D0 (en) | Use of heterocyclic compounds | |
| GB9112274D0 (en) | Use of heterocyclic compounds | |
| GB9112309D0 (en) | Use of heterocyclic compounds | |
| HU9400358D0 (en) | Use of quinoziline derivatives as orexigenics | |
| GB8805772D0 (en) | Formula for treatment of burns | |
| GB9123161D0 (en) | Treatment of neurological conditions | |
| GB2206821B (en) | Improvements relating to surface treatment |